Malaria Prevention for Kenya Safari Travellers: The Full Guide

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — Professor of Public Health, David Tvildiani Medical University.

Malaria remains the most significant preventable health risk for travellers to sub-Saharan Africa. Kenya has year-round malaria transmission across most of its safari regions, with risk peaking during and immediately after the rainy seasons. The disease is preventable through a combination of chemoprophylaxis, mosquito bite avoidance and prompt treatment of fever. Understanding the evidence behind each intervention allows travellers to make informed decisions in consultation with their travel medicine physician.

Malaria Risk in Kenya’s Safari Regions

Kenya’s malaria risk is not uniform. The Masai Mara (altitude approximately 1,500 m) has lower mosquito density than coastal or low-altitude areas but is not malaria-free — Anopheles mosquitoes are present and Plasmodium falciparum transmission occurs. Samburu National Reserve (900 m) and Tsavo (500–600 m) have higher risk. Nairobi (1,700 m) is considered low risk but not zero risk. The Kenyan highlands above 2,500 m are generally malaria-free. Travellers whose itinerary includes coastal Kenya (Mombasa, Lamu) face the highest transmission risk.

WHO Global Malaria Report (2023): Kenya recorded approximately 5.5 million confirmed malaria cases in 2022, with the highest transmission burden in the Lake Victoria basin and coastal regions. Travellers to high-transmission areas who take no chemoprophylaxis face an estimated risk of 1–3% per month of exposure of acquiring malaria. With appropriate chemoprophylaxis and bite avoidance, risk falls to below 0.1%.

Chemoprophylaxis Options: Evidence and Practical Considerations

Atovaquone-proguanil (Malarone): Highly effective against P. falciparum in Kenya. Taken daily, starting 1–2 days before travel and for 7 days after return. Well-tolerated with few side effects. The drug of choice for most short-term travellers. Requires a prescription. Cost is higher than other options per week of travel but total cost for a two-week safari is manageable.

Doxycycline: Effective and low-cost. Taken daily, starting 1–2 days before travel and for 28 days after return. Requires rigorous sun protection (significant photosensitivity side effect) and should be taken with food and a full glass of water to prevent oesophageal irritation. Not suitable for pregnant women or children under 8 years.

Mefloquine (Lariam): Weekly dosing is convenient. However, neuropsychiatric side effects — vivid dreams, anxiety, dizziness, depression — affect a significant minority of users. Requires a test dose 2–3 weeks before travel to assess individual tolerability. Not recommended as first-line for most travellers unless the weekly dosing regimen is a significant practical advantage.

Bite Avoidance: Non-Negotiable

DEET-based repellents at concentrations of 30–50% provide the most reliable protection and have an excellent safety record when used as directed. Apply to all exposed skin at dusk and throughout evening activities. Permethrin treatment of clothing and bed nets provides supplementary protection. Safari camps universally provide insect screens on tent and room windows; always check that screens are intact and close them before dusk. Game drives at dusk — the time of highest mosquito activity — require long sleeves, long trousers and repellent on all exposed skin including the back of the hands and neck.

Frequently Asked Questions

What should I do if I develop fever during or after my safari?
Any fever occurring during travel or within 3 months of return from a malaria-endemic area should be treated as malaria until proved otherwise. Seek medical attention immediately. Inform the treating physician of your travel history. Do not wait to see if the fever resolves — P. falciparum malaria can progress to severe illness within 24–48 hours of symptom onset.

Are children at higher risk of malaria?
Children have less immunity than adults who have lived their entire lives in non-malaria regions, and severe malaria progresses faster in children. Chemoprophylaxis is essential for children travelling to malaria-endemic areas. Doxycycline is not suitable for children under 8; atovaquone-proguanil is the preferred option. Paediatric dosing should be confirmed with a travel medicine physician.

Is there a malaria vaccine?
The RTS,S/AS01 (Mosquirix) vaccine is approved and being rolled out in sub-Saharan Africa for young children in high-transmission areas. It is not currently recommended for or widely available to adult travellers as a substitute for chemoprophylaxis. Research on more effective traveller vaccines continues.

Can I buy antimalarials locally in Kenya?
Yes, antimalarials are available from pharmacies in Nairobi and other cities. However, quality control and counterfeiting are genuine concerns. Starting your prescribed regimen before departure with a pharmacy you trust is strongly recommended over relying on local procurement.